NEWS & INSIGHTS

MoneyTalks: Pengana’s James McDonald reveals his top three ASX biotechs

MoneyTalks is Stockhead’s regular drill down into what stocks investors are looking at right now. We’ll tap our extensive list of experts...

Pengana tips this tiddler to grow into a ‘multibillion-dollar’ stock

Jeremy Bendeich is co-portfolio manager of the Pengana High Conviction Equities Fund. The Sydney-based firm oversees about $3.5 billion in...

CEO calls for clearer distinction between Australian and global private credit

A CEO has emphasised the importance of distinguishing between private credit in Australia and abroad, highlighting their significantly different risk...

How Microsoft Became the Business World’s Portal to Generative AI

After missing out on the smartphone era, the company made its software indispensable to the workplace. Now, as businesses look...

Dominating the Weight-Loss Market: Eli Lilly and Novo Nordisk

US-based Eli Lilly and Denmark’s Novo Nordisk dominate the fast-growing global market for weight-loss drugs. The World Health Organisation estimates...

Pengana Capital Group